" class="no-js "lang="en-US"> Nanoform - Medtech Alert
Thursday, June 19, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Nanoform | Pharmtech Focus

Nanoform

About Nanoform

Nanoform

Nanoform is an innovative nanoparticle medicine enabling company that supplies best in class nanoforming services. Our multi-patented CESS® technology can double the amount of lead compounds progressing into clinic, leading to a significant increase in the number of drugs that reach the market. The green particle engineering process produces pure and stable nanoparticles as small as 10 nm using supercritical carbon dioxide.

Related Story

Artificial Intelligence

 Nanoform Launches "STARMAP® Online" Placing AI-power at the Fingertips of Medicine Developers | Pharmtech Focus

Nanoform Launches "STARMAP® Online" Placing AI-power at the Fingertips of Medicine Developers

May 4 2022

Nanoform Finland Plc., an innovative nanoparticle medicine-enabling company, today announced that it has launched its […]

Fundraising

 Nanoform Receives Funding to Solve Challenges for Global Health | Pharmtech Focus

Nanoform Receives Funding to Solve Challenges for Global Health

September 30 2021

Nanoform, an innovative nanoparticle medicine enabling company, announces that Proof of Concept studies will be […]

Drug Development

 Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines | Pharmtech Focus

Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines

April 21 2021

Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3DP (three-dimensional printing) […]